Results 31 to 40 of about 222,471 (336)

University vaccine campaign increases meningococcal ACWY vaccine coverage [PDF]

open access: yesPublic Health, 2017
The file associated with this record is embargoed until 12 months after the date of publication. The final published version may be available through the links above. Following the embargo period the above license applies. ; In this study, we report MenACWY vaccine coverage in first year students arriving at the University of Nottingham (UoN) in ...
D.P.J. Turner   +2 more
openaire   +4 more sources

Age-appropriate vaccination coverage and its determinants for the polio containing vaccine 1-3 and measles-containing vaccine doses in Zhejiang province, China: A community-based cross-sectional study

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Background: This study aimed to evaluate the age-appropriate coverage and its associated risk factors for the primary vaccination of Polio containing vaccine (PCV) and measles-containing vaccine (MCV) through the secondary use of the 2018 Zhejiang ...
Yu Hu   +4 more
doaj   +1 more source

Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp. [PDF]

open access: yes, 1996
Serogroup A meningococcus epidemics occurred in refugee populations in Zaire in August 1994. The paper analyses the public health impact of a mass vaccination campaign implemented in a large refugee camp.
Blok, L   +5 more
core   +2 more sources

Longitudinal profiling of the vaccination coverage in Brazil reveals a recent change in the patterns hallmarked by differential reduction across regions

open access: yesInternational Journal of Infectious Diseases, 2020
Objective: Vaccination coverage is decreasing worldwide, favoring the potential reemergence of vaccine-preventable diseases. In this study, we performed a longitudinal characterization of vaccination coverage in Brazil and compared the profiles between ...
Náthaly Césare   +8 more
doaj   +1 more source

Predictors of measles vaccination coverage among children 6-59 months of age in the Democratic Republic of the Congo. [PDF]

open access: yes, 2018
BackgroundMeasles is a significant contributor to child mortality in the Democratic Republic of the Congo (DRC), despite routine immunization programs and supplementary immunization activities (SIA).
Alfonso, Vivian H   +10 more
core   +1 more source

Determinants of vaccination coverage and consequences for rabies control in Bali, Indonesia [PDF]

open access: yes, 2017
Maintaining high vaccination coverage is key to successful rabies control, but mass dog vaccination can be challenging and population turnover erodes coverage.
Arief, Riana A.   +15 more
core   +2 more sources

Spatial clustering of measles vaccination coverage among children in sub-Saharan Africa

open access: yesBMC Public Health, 2017
Background During the past two decades, vaccination programs have greatly reduced global morbidity and mortality due to measles, but recently this progress has stalled.
Tenley K. Brownwright   +2 more
doaj   +1 more source

Coverage of primary and booster vaccination against COVID-19 by socioeconomic level: A nationwide cross-sectional registry study

open access: yesHuman Vaccines & Immunotherapeutics, 2023
High and equitable COVID-19 vaccination coverage is important for pandemic control and prevention of health inequity. However, little is known about socioeconomic correlates of booster vaccination coverage.
Bo T. Hansen   +3 more
doaj   +1 more source

Sustained Increase in Very Low Influenza Vaccination Coverage in Residents and Healthcare Workers of Long-Term Care Facilities in Austria after Educational Interventions

open access: yesVaccines, 2023
Residents of long-term care facilities (LTCFs) are particularly at risk for influenza infections. We aimed to improve influenza vaccination coverage among residents and healthcare workers (HCWs) in four LTCFs by implementing educational programs and ...
Johannes Boyer   +7 more
doaj   +1 more source

Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010. [PDF]

open access: yesPLoS ONE, 2012
MenAfriVac is a new conjugate vaccine against Neisseria meningitidis serogroup A developed for the African "meningitis belt". In Niger, the first two phases of the MenAfriVac introduction campaign were conducted targeting 3,135,942 individuals aged 1 to ...
Sung Hye Kim   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy